Alnylam founding CEO Maraganore steps down
29 Oct 2021 //
FIERCEPHARMA
Millennium Health Study Reveals Nationwide Increase in Urine Drug Test
05 Jan 2021 //
PRNEWSWIRE
Jardiance (empagliflozin) : Boehringer Ingelheim vs. MSN Labs
24 Nov 2018 //
PATENT LITIGATION
Velcade (Bortezomib): Millennium Pharmaceuticals vs Hetero Labs Limited
24 Nov 2018 //
PATENT LITIGATION
Jardiance (empagliflozin) : Boehringer Ingelheim vs. Zydus Pharms
20 Nov 2018 //
PATENT LITIGATION
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Sun Pharma
01 Nov 2018 //
PATENT LITIGATION
Enforcement Report - Week of February 14, 2018
14 Feb 2018 //
FDA
OvaScience Pinks Slips Nearly 50% of Workforce
04 Jan 2018 //
BIOSPACE
Jounce Names Ex-Ariad`s Top Dealmaker as Its New CBO
16 Aug 2017 //
BIOSPACE
Takeda, Abingworth Infuse $100 Million Into a Tiny Biotech, Sealing for M&A
10 May 2017 //
BIOSPACE
Velcade (Bortezomib): Millennium Pharmaceuticals v. Zydus Pharmaceuticals
13 Apr 2017 //
PATENT LITIGATION
Velcade (Bortezomib): Millennium Pharmaceuticals v. Amneal Pharmaceuticals
13 Apr 2017 //
PATENT LITIGATION
Zebra subway car runs through Boston to draw attention to rare diseases
07 Feb 2017 //
FIERCE PHARMA
Checkmate raises $27M as I-O program gathers pace
17 Jun 2016 //
FIERCE BIOTECH
After Failed Trial, Forum CEO Dunsire Leaves, Company’s Fate Unclear
25 May 2016 //
XCONOMY
Takeda`s `breakthrough` Velcade heir wins early FDA approval in myeloma
20 Nov 2015 //
FIERCE BIOTECH
Oligodendroglioma Pipeline Products/Drug Profile Reviewed in H2 2015 Report
16 Nov 2015 //
PR NEWSWIRE